Dumont & Blake Investment Advisors LLC cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,353 shares of the medical research company’s stock after […]
Bell Bank decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,716 shares of the medical research company’s stock after selling 146 shares during the period. Bell Bank’s holdings in Charles River […]
Reinhart Partners LLC. lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,895 shares of the medical research company’s stock after selling 16,174 shares […]
Reinhart Partners LLC. cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the 4th quarter, Holdings Channel reports. The fund owned 72,895 shares of the medical research company’s stock after selling 16,174 shares during the quarter. Reinhart Partners LLC.’s holdings in Charles River Laboratories International were […]
Provence Wealth Management Group acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The firm acquired 292 shares of the medical research company’s stock, valued at approximately $57,000. Several other institutional investors and hedge funds have also recently modified their holdings of […]